55% of HME respondents say mask selection is the biggest challenge during remote CPAP setups in a recent survey SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed ...

High-rolling investors have positioned themselves bullish on ResMed (NYSE:RMD), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...

Financial giants have made a conspicuous bearish move on ResMed. Our analysis of options history for ResMed (NYSE:RMD) revealed 10 unusual trades. Delving into the details, we found 20% of traders ...

ResMed (NYSE:RMD) intends to keep its CPAP masks that utilize magnets on the market despite a recall because it regards the action as a labeling correction rather than a product removal. According to ...

SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea ...

Pre-earnings options volume in ResMed (RMD) is 3.5x normal with puts leading calls 7:5. Implied volatility suggests the market is anticipating a move near 6.9%, or $16.63, after results are released.

ResMed is taking a “smart devices” and “big data” approach to further entrench itself as one of the two leading players in the global sleep apnea market. The strategy is two-fold – accelerating ...

A CPAP machine is a medical device often recommended to folks who have sleep apnea or other disruptive sleep conditions. Wearers place a mask over their nose and mouth to deliver a continuous stream ...

As competitor Philips continues to grapple with the effects of its long-standing recall of continuous positive airway pressure (CPAP) machines and other respiratory devices, ResMed is now issuing a ...